Articles From: Zogenix Takes Legal Action in Federal Court to Block Massachusetts Improper Ban on Zohydro™ ER to Prima BioMed to Present at 13th Annual Needham Healthcare Conference


2014/4/7
Company Files for Injunction - Prescription Drug Status Should Reside Solely With the FDA SAN DIEGO , April 7, 2014 /PRNewswire/ --  Zogenix, Inc. (Nasdaq: ZGNX) , a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today filed a lawsuit in the U.S. District Court in Massachusetts requesting the court to grant a temporary restraining order against execution of the executive order recently announced by Governor Deval Patrick , which prohibits the prescribing and dispensing of the Company's prescription pain product that was approved by the U.S. Food and Drug Administration (FDA). Zohydro™ ER (hydrocodone bitartrate) extended-release capsules, is the first and only extended-release hydrocodone without acetaminophen for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Sign-up for Zogenix Takes Legal Action in Federal Court to Block Massachusetts Improper Ban on Zohydro™ ER investment picks
2014/4/7
http://media.marketwire.com/attachments/201302/124632_logomill.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104652&ProfileId=051205&sourceType=1 KNOXVILLE, TN --
Sign-up for / CORRECTION - Miller Energy Resources investment picks
2014/4/7
In the news release, BioMed Realty Invests In Life Science Research Facilities Leased To Yale University , Yale-New Haven Hospital And Alexion Pharmaceuticals, issued 07-Apr-2014 by BioMed Realty over PR Newswire, we are advised by the company that the 4th paragraph, 1st sentence, should read "...a global pharmaceutical company with a marketed product, Soliris®..." rather than, "...a global pharmaceutical company with a marketed product, Solaris®..." as originally issued inadvertently.
Sign-up for /C O R R E C T I O N -- BioMed Realty/ investment picks
2014/4/7
http://media.marketwire.com/attachments/201403/72516_flamel.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104523&ProfileId=051205&sourceType=1 LYON, FRANCE --
Sign-up for /CORRECTION - Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial With Micropump Sodium Oxybate investment picks
2014/4/7
SALT LAKE CITY , April 7, 2014 /PRNewswire/ -- For the second year in a row, USANA , a nutritional company at the forefront of the health and wellness industries, held its RESET Challenge : Destination Transformation to support individuals from all walks of life in their weight loss efforts and overall well-being.
Sign-up for #Weightloss: Thousands Lose Weight in Just 12 Weeks With @USANAInc RESET™ Challenge investment picks
2014/4/7
#Weightloss: Thousands Lose Weight in Just 12 Weeks With @USANAInc RESET™ Challenge Canada NewsWire SALT LAKE CITY , April 7, 2014 /CNW/ - For the second year in a row, USANA , a nutritional company at the forefront of the health and wellness industries, held its RESET Challenge : Destination Transformation to support individuals from all walks of life in their weight loss efforts and overall well-being.
Sign-up for #Weightloss: Thousands Lose Weight in Just 12 Weeks With @USANAInc RESET™ Challenge investment picks
2014/4/7
World leading florist deliv-ers smiles with an enhanced delivery experience PALO ALTO, Calif.
Sign-up for 1-800-FLOWERS.COM Teams with Deliv for Same-Day Delivery investment picks
2014/4/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104494&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for 3D Pioneer Systems Enters Into Development Agreement With MCAST investment picks
2014/4/6
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, announced that data from its lead, first-in-class program AG-221 will be presented today at a Clinical Trials Symposium titled “Novel Immune and Targeted Therapies for Hematological Malignancies and Solid Tumors” at the American Association for Cancer Research (AACR) Annual Meeting 2014.
Sign-up for Agios Announces Initial Phase 1 Data Demonstrating Clinical Activity of AG-221, First-in-Class Inhibitor of IDH2 Mutations, in Patients with Advanced Blood Cancers investment picks
2014/4/6
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Announces First Quarter 2014 Financial Results investment picks
2014/4/6
Asian stocks fell Monday, with a rout Friday in U.S. technology stocks also taking hold in Tokyo.
Sign-up for Asian Shares Down as Tech Stocks Fall investment picks
2014/4/6
By Eric Yep SINGAPORE--BG Group PLC (BG.LN) said Monday it will manage its international liquefied natural gas and oil marketing business from Singapore because of the importance of Asian energy markets.
Sign-up for BG Group Moves International LNG, Oil Marketing Business to Singapore investment picks
2014/4/6
Paint rollout reveals 787-9 launch customer's new-look livery Airplane scheduled for delivery in mid-2014 787-9 to carry more passengers further, with exceptional fuel efficiency EVERETT, Wash.
Sign-up for Boeing, Air New Zealand Unveil Livery of First 787-9 Dreamliner to Deliver investment picks
2014/4/6
Cameron Dye (of Boulder, CO) won the male professional division in 1:51.56 and Sarah Haskins (of Clermont, FL) won the female professional division in 2:01.59 at today’s 2014 Life Time Tri South Beach.
Sign-up for Cameron Dye and Sarah Haskins Top Finishers at 2014 Life Time Tri South Beach investment picks
2014/4/6
NETANYA, Israel , April 6, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces MOC Approval For Change Of Indirect Controlling Shareholders investment picks
2014/4/6
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of early findings from studies exploring the relationship between tumor PD-L1 expression and clinical outcomes following monotherapy treatment with MK-3475, an investigational anti-PD-1 immunotherapy, in patients with advanced melanoma and advanced non-small cell lung cancer (NSCLC). Responses were observed in patients with PD-L1 negative tumors; although the preliminary findings for both tumor types suggest that higher PD-L1 expression was associated with higher overall response rates.
Sign-up for Early Findings Exploring the Relationship of PD-L1 Expression and Clinical Outcomes with MK-3475, Merck’s Investigational Anti-PD-1 Immunotherapy, Presented at AACR Annual Meeting 2014 investment picks
2014/4/6
FRANKFURT--Russian energy monopoly Gazprom has assured Germany that its gas supply from Russia is secure despite diplomatic tensions related to Ukraine.
Sign-up for Gazprom Promises to Keep Gas Flow to Germany Open-Report investment picks
2014/4/6
http://media.marketwire.com/attachments/201404/TN-237959_149_dreamcolor.jpg HP DreamColor Displays set new levels of affordability and color accuracy.
Sign-up for HP Unveils New DreamColor Displays Offering Unmatched Color Accuracy and Affordability investment picks
2014/4/6
Interval International, a prominent worldwide provider of vacation services and an operating business of Interval Leisure Group (Nasdaq: IILG), announced the affiliation of The Resort at Diamante, a shared ownership property within Diamante Cabo San Lucas.
Sign-up for Interval International Welcomes Stunning Property in Los Cabos — the Resort at Diamante investment picks
2014/4/6
INDIANAPOLIS , April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif.
Sign-up for Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014 investment picks
2014/4/6
ROCKVILLE, Md., April 6, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX) , a clinical-stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced the presentation of pre-clinical data demonstrating that MGD007, a dual-affinity re-targeting (DART®) protein, has potent activity against colorectal cancer cells both in vitro and in vivo .
Sign-up for MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting investment picks
2014/4/6
By Drew Hinshaw and Patrick McGroarty ABUJA, Nigeria--Nigeria has surpassed South Africa as the largest economy in Africa, after the government on Sunday released its first full measure of the economy for the continent's most-populous country.
Sign-up for Nigeria's economy surpasses South Africa's investment picks
2014/4/6
By Ruth Bender PARIS--French cable operator Numericable Group SA (NUM.FR) will launch a rights issue of up to EUR4.7 billion euros to help finance its acquisition of Vivendi SA's (VIVEF, VIV.FR) phone unit SFR, the group's parent company Altice SA (ATC.AE) said Sunday.
Sign-up for Numericable to Launch EUR4.7 Billion Rights Issue to Finance SFR Buy investment picks
2014/4/6
OGC Q1 2014 financial results conference call / webcast Canada NewsWire /NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES AND NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES./ MELBOURNE , April 7, 2014 /CNW/ - OceanaGold Corporation's financial and operational results for the quarter ended 31 March 2014 will be released following the close of the ASX market on Tuesday 29 April ( Melbourne, Australia time) and will be posted on OceanaGold's website at www.oceanagold.com .
Sign-up for OGC Q1 2014 financial results conference call / webcast investment picks
2014/4/6
FORT WORTH, Texas , April 6, 2014 /PRNewswire/ -- The Sultanate of Oman accepted the first of its second order of Lockheed Martin [NYSE: LMT] F-16 Fighting Falcons in a ceremony April 3 at Lockheed Martin's Fort Worth facility.
Sign-up for Oman Air Force Continues F-16 Legacy investment picks
2014/4/6
Pfizer Inc. today announced detailed results from the PALOMA-1 study, a randomized Phase 2 study of palbociclib (PD-0332991) in combination with letrozole.
Sign-up for Pfizer’s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer investment picks
2014/4/6
Tilk to assume CEO role in July 2014 ; Doyle to continue as Senior Advisor until June 2015 , allowing for planned and seamless transition Listed: TSX, NYSE Symbol: POT SASKATOON , April 6, 2014 /PRNewswire/ - Potash Corporation of Saskatchewan Inc. (PotashCorp) today announced that the Board of Directors has appointed Jochen Tilk as President and CEO, effective July 1, 2014 .
Sign-up for PotashCorp Announces Selection of Jochen Tilk as Next President and CEO investment picks
2014/4/6
PotashCorp Announces Selection of Jochen Tilk as Next President and CEO Canada NewsWire Tilk to assume CEO role in July 2014 ; Doyle to continue as Senior Advisor until June 2015 , allowing for planned and seamless transition Listed: TSX, NYSE Symbol: POT SASKATOON , April 6, 2014 /CNW/ - Potash Corporation of Saskatchewan Inc. (PotashCorp) today announced that the Board of Directors has appointed Jochen Tilk as President and CEO, effective July 1, 2014 .
Sign-up for PotashCorp Announces Selection of Jochen Tilk as Next President and CEO investment picks
2014/4/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104425&ProfileId=051205&sourceType=1 SYDNEY, AUSTRALIA --
Sign-up for Prima BioMed to Present at 13th Annual Needham Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Zogenix Takes Legal Action in Federal Court to Block Massachusetts Improper Ban on Zohydro™ ER to Prima BioMed to Present at 13th Annual Needham Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity